Physician

Peter John Morrell, D.O.

According to 2025 Medicare claims, Peter Morrell, D.O. (NPI: 1679809362) practices dermatology in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is MORRELL DERMATOLOGY, P.A. (NPI: 1033485669; TIN: 454819441) and primary practice location at 77706-3000.

Morrell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,999 traditional Medicare patients, billed 8,464 HCPCS/CPT codes, and received $824,883 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 5,063 prescription claims across 1,746 beneficiaries totaling $1,571,260 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 77 records totaling $1,705. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $550,104 to $824,883. Similarly, Part D prescription costs have moved sharply higher in recent years, from $455,003 to $1,571,260. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$412K$825K2015 Medicare payment: $550,104 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $456,749 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $441,379 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $500,488 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $577,977 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $446,626 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $547,446 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $596,636 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $650,987 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $824,883 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,6907,026$550,104
20161,8017,285$456,749
20171,7226,873$441,379
20181,6647,304$500,488
20191,8978,021$577,977
20201,4926,036$446,626
20211,4716,373$547,446
20221,6647,086$596,636
20231,9288,048$650,987
20241,9998,464$824,883

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$786K$1.6M2015 Drug cost: $455,003 (USD; Tot_Drug_Cst)2016 Drug cost: $479,765 (USD; Tot_Drug_Cst)2017 Drug cost: $532,304 (USD; Tot_Drug_Cst)2018 Drug cost: $584,480 (USD; Tot_Drug_Cst)2019 Drug cost: $596,053 (USD; Tot_Drug_Cst)2020 Drug cost: $608,580 (USD; Tot_Drug_Cst)2021 Drug cost: $718,738 (USD; Tot_Drug_Cst)2022 Drug cost: $701,402 (USD; Tot_Drug_Cst)2023 Drug cost: $1,093,149 (USD; Tot_Drug_Cst)2024 Drug cost: $1,571,260 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20158972,514$455,003
20161,0843,117$479,765
20171,2213,213$532,304
20181,3073,592$584,480
20191,3383,854$596,053
20201,1143,264$608,580
20211,2193,482$718,738
20221,3713,930$701,402
20231,5784,450$1,093,149
20241,7465,063$1,571,260

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths543616$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more674868$63
11102Biopsy of related skin growth, first growth505568$62
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more715898$37
17000Destruction of precancer skin growth, 1 growth567651$36

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa221,736$453,626
Taltz AutoinjectorIxekizumab331,036$247,866
Dupixent PenDupilumab591,666$230,476
RinvoqUpadacitinib14540$112,771
Clobetasol PropionateClobetasol Propionate58815,807$20,883

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.77$1,705ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Peter John Morrell, D.O.?

Tedicare shows public-source Medicare data for Peter John Morrell, D.O. (NPI 1679809362), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter John Morrell, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter John Morrell, D.O.?

Peter John Morrell, D.O. is linked to MORRELL DERMATOLOGY, P.A. (billing NPI 1033485669) in the available physician profile data.

Does Peter John Morrell, D.O. have Open Payments data?

Peter John Morrell, D.O. has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.